NO148960C - Fremgangsmaate ved in vitro-bestemmelse av den biologiske aktiviteten til faktor xa-inhibitor i blodplasma - Google Patents

Fremgangsmaate ved in vitro-bestemmelse av den biologiske aktiviteten til faktor xa-inhibitor i blodplasma

Info

Publication number
NO148960C
NO148960C NO764081A NO764081A NO148960C NO 148960 C NO148960 C NO 148960C NO 764081 A NO764081 A NO 764081A NO 764081 A NO764081 A NO 764081A NO 148960 C NO148960 C NO 148960C
Authority
NO
Norway
Prior art keywords
inhibitor
factor
procedure
biological activity
blood plasma
Prior art date
Application number
NO764081A
Other languages
English (en)
Other versions
NO148960B (no
NO764081L (no
Inventor
Ee T Yin
Oddvar Tangen
Original Assignee
Pharmacia Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia Ab filed Critical Pharmacia Ab
Publication of NO764081L publication Critical patent/NO764081L/no
Publication of NO148960B publication Critical patent/NO148960B/no
Publication of NO148960C publication Critical patent/NO148960C/no

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/86—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood coagulating time or factors, or their receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/81—Protease inhibitors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/914—Hydrolases (3)
    • G01N2333/948—Hydrolases (3) acting on peptide bonds (3.4)
    • G01N2333/95—Proteinases, i.e. endopeptidases (3.4.21-3.4.99)
    • G01N2333/964—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue
    • G01N2333/96425—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals
    • G01N2333/96427—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general
    • G01N2333/9643—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general with EC number
    • G01N2333/96433—Serine endopeptidases (3.4.21)
    • G01N2333/96441—Serine endopeptidases (3.4.21) with definite EC number
    • G01N2333/96444—Factor X (3.4.21.6)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2400/00—Assays, e.g. immunoassays or enzyme assays, involving carbohydrates
    • G01N2400/10—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • G01N2400/38—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence, e.g. gluco- or galactomannans, e.g. Konjac gum, Locust bean gum, Guar gum
    • G01N2400/40—Glycosaminoglycans, i.e. GAG or mucopolysaccharides, e.g. chondroitin sulfate, dermatan sulfate, hyaluronic acid, heparin, heparan sulfate, and related sulfated polysaccharides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
NO764081A 1975-12-01 1976-11-30 Fremgangsmaate ved in vitro-bestemmelse av den biologiske aktiviteten til faktor xa-inhibitor i blodplasma NO148960C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE7513495A SE419871B (sv) 1975-12-01 1975-12-01 Sett att bestemma aktiviteten hos faktor xa-inhibitor i blod

Publications (3)

Publication Number Publication Date
NO764081L NO764081L (no) 1977-06-02
NO148960B NO148960B (no) 1983-10-10
NO148960C true NO148960C (no) 1984-01-18

Family

ID=20326201

Family Applications (1)

Application Number Title Priority Date Filing Date
NO764081A NO148960C (no) 1975-12-01 1976-11-30 Fremgangsmaate ved in vitro-bestemmelse av den biologiske aktiviteten til faktor xa-inhibitor i blodplasma

Country Status (15)

Country Link
US (1) US4139415A (no)
JP (1) JPS5915640B2 (no)
AT (1) AT348687B (no)
AU (1) AU508343B2 (no)
BE (1) BE848932A (no)
CA (1) CA1060324A (no)
CH (1) CH625052A5 (no)
DE (1) DE2654189C3 (no)
DK (1) DK537676A (no)
FI (1) FI63494C (no)
FR (1) FR2334109A1 (no)
GB (1) GB1562808A (no)
NL (1) NL7613376A (no)
NO (1) NO148960C (no)
SE (1) SE419871B (no)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2757992A1 (de) * 1977-12-24 1979-06-28 Boehringer Mannheim Gmbh Verfahren zur prothrombin-bestimmung
US4302538A (en) * 1978-03-27 1981-11-24 Ortho Diagnostics Inc. Buffer system in an anti-thrombin III test
SE422081B (sv) * 1979-08-22 1982-02-15 Ird Biomaterial Ab Sett att pavisa proteolytiska enzymer
CA1161432A (en) * 1980-02-12 1984-01-31 Lars G. Svendsen Tripeptide derivatives and their application in assaying enzymes
JPH0258920B2 (no) * 1980-10-09 1990-12-11 Boehringer Mannheim Gmbh
US4753875A (en) * 1981-11-02 1988-06-28 Ryan James W Method for assaying proteases with tagged proteinaceous inhibitors
US5221614A (en) * 1988-03-03 1993-06-22 Nippon Shoji Kabushiki Kaisha Method and reagent for determining the biological activity of antithrombin III by measuring coagulation time
GB9602166D0 (en) * 1996-02-02 1996-04-03 Zeneca Ltd Aminoheterocyclic derivatives
DE19634312A1 (de) * 1996-08-24 1998-02-26 Behringwerke Ag Verfahren zur Herstellung von Faktor V-Mangelplasma und ein so erhaltenes Mangelplasma
US6432658B1 (en) 2000-09-13 2002-08-13 Affinity Biologicals, Inc. Method for measuring antithrombin activity
EP2818871A1 (en) * 2013-06-28 2014-12-31 Roche Diagniostics GmbH Means and methods for universal calibration of anti-Factor Xa tests

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE380257B (sv) * 1972-05-02 1975-11-03 Bofors Ab Nya diagnostiskt verksamma substrat med hog specificitet till trombin och andra proteolytiska enzymer av typen peptidyl-peptid-hydrolaser
US3985618A (en) * 1975-05-02 1976-10-12 Irving Innerfield Method for detection of thrombosis and prethrombosis

Also Published As

Publication number Publication date
SE7513495L (sv) 1977-06-02
DE2654189B2 (de) 1979-03-08
FR2334109B1 (no) 1982-03-12
ATA891076A (de) 1978-07-15
SE419871B (sv) 1981-08-31
GB1562808A (en) 1980-03-19
FI63494C (fi) 1983-06-10
AU2006176A (en) 1978-06-08
NO148960B (no) 1983-10-10
CH625052A5 (no) 1981-08-31
DK537676A (da) 1977-06-02
FI63494B (fi) 1983-02-28
BE848932A (fr) 1977-05-31
FR2334109A1 (fr) 1977-07-01
DE2654189A1 (de) 1977-06-08
AT348687B (de) 1979-02-26
JPS5915640B2 (ja) 1984-04-10
FI763446A (no) 1977-06-02
NL7613376A (nl) 1977-06-03
NO764081L (no) 1977-06-02
DE2654189C3 (de) 1985-10-03
JPS5297792A (en) 1977-08-16
US4139415A (en) 1979-02-13
CA1060324A (en) 1979-08-14
AU508343B2 (en) 1980-03-20

Similar Documents

Publication Publication Date Title
NO781297L (no) Fremgangsmaate ved behandling av hydrokarbongasser
DD137355A5 (de) Verfahren zur herstellung von phthalazin-derivaten
DK432075A (da) Til flere formal bestemt fortyndingsmiddel til brug ved blodanalyse med elektroninstrument af coultertypen
NO148712C (no) Fremgangsmaate ved fremstilling av etylidendiacetat
GB1540441A (en) Treatment of blood plasma
SE431255B (sv) Forfarande for bestemning av graden av notning
NO148960C (no) Fremgangsmaate ved in vitro-bestemmelse av den biologiske aktiviteten til faktor xa-inhibitor i blodplasma
NO138454C (no) Fremgangsmaate ved antikorrosjonsbehandling av zirkoniumlegeringer
DD134088A5 (de) Verfahren zur herstellung von neuen pyrrolidinderivaten
BE868544A (fr) Composition contenant du dithranol pour le traitement du psoriasis
NO144297C (no) Fremgangsmaate ved oxydasjon av titanjernmalmer
NO149737C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive 1-azaxanthon-3-carboxylsyrer
AT353968B (de) Verfahren zur herstellung von (14-14c)- daunorubicin und(14-14c)-doxorubicin
ATA387076A (de) Verfahren zur herstellung von homo- und copolymerisaten des tetrafluorathylens
NO144325C (no) Fremgangsmaate ved fremstilling av rustfritt staal av basismetall i oppdelt form.
AT348548B (de) Verfahren zur herstellung von alsblutplasma- expander geeignerter hydroxyaethylstaerke
IT1105624B (it) Procedimento per il trattamento di fanhiglie di scarico
PT65749A (de) Verfahren zur herstellung von 1-(2-halogen-2-phenyl-athyl)-triazole und ihre verwendung als fungizide
IT1174284B (it) Procedimento per il trattamento di rivelatori di ossigeno in gas di scarico
BR7800822A (pt) Process for the preparation of new esters
NO145620C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive depotsteroidestere.
AT338162B (de) Etagenofen zur thermischen behandlung von schlammformigen materialien, insbesondere von magnesithydratschlammen
NO150040C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive 2-azetidinoner
LU79271A1 (de) Verfahren zur herstellung von neuen derivaten des 9-fluorprednisolons
NO152652C (no) Analogifremgamgsmaate ved fremstilling av terapeutisk aktive cycloalkenchromonderivater.